Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: John Thompson, Christopher Cunniff

Premium

Transgenomics has appointed John Thompson as a Class II director of the firm. He will also serve on the audit committee of the company's board of directors. Thompson was previously senior vice president of strategy and corporate development at Invitrogen and was also previously senior vice president of strategy and business development at Dexter.


New York-Presbyterian/Weill Cornell Medical Center has appointed Christopher Cunniff to the director of the division of medical genetics. Previously, Cunniff was chief of medical and molecular genetics at the University of Arizona College of Medicine. He also served as co-medical director of the Children's Clinics for Rehabilitative Services and was recently a professor of pediatrics with joint appointments in pathology, public health, and obstetrics and gynecology at the University of Arizona College of Medicine. He also previously served as secretary of the American College of Medical Genetics and as president of the American Board of Medical Genetics.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.